Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa

Journal of Clinical Virology

Volumn 49, Issue 1, 2010, Pages 61-64

  Njouom, Richard ^a   Nerrienet, Eric ^a   Budkowska, Agata ^b   Maillard, Patrick ^b   Rousset, Dominique ^a   Kalinina, Olga ^c   Mavromara, Penelope ^d  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b INSTITUT PASTEUR   (France)

^c ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^d HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Antibodies; Cameroon; Core; Hepatitis C; NS4B; Peptides

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C CORE PEPTIDE; NONSTRUCTURAL PROTEIN 4B; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; CAMEROON; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

EID: 77955658750     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.06.005     Document Type: Article

References (14)

1. Kanistanon D., Neelamek M., Dharakul T., Songsivilai S. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays. Asian Pac J Allergy Immunol 1997, 15:133-140.
2. Neville J.A., Prescott L.E., Bhattacherjee V., Adams N., Pike I., Rodgers B., et al. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus. J Clin Microbiol 1997, 35:3062-3070.
3. Dow B.C., Munro H., Buchanan I., Follett E.A., Davidson F., Yap P.L., et al. Third-generation recombinant immunoblot assay: comparison of reactivities according to hepatitis C virus genotype. Transfusion 1996, 36:547-551.
4. Halfon P., Bourliere M., Khiri H., Halimi G., Gerolami V., Feryn J.M., et al. Serological response to infection with different isolates of hepatitis C virus. J Viral Hepat 2002, 9:438-442.
5. Rodriguez-Lopez M., Riezu-Boj J.I., Ruiz M., Berasain C., Civeira M.P., Prieto J., et al. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA. J Gen Virol 1999, 80(Pt 3):727-738.
6. Pasquier C., Njouom R., Ayouba A., Dubois M., Sartre M.T., Vessiere A., et al. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J Med Virol 2005, 77:390-398.
7. Beld M., Penning M., van Putten M., Lukashov V., van den Hoek A., McMorrow M., et al. Quantitative antibody responses to structural (core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 1999, 29:1288-1298.
8. Atherton E., Logan C., Sheppard R. Peptide synthesis. Part 2. Bioorg Chem 1979, 8:351-370.
9. Muerhoff A.S., Gutierrez R., Kyrk C., Leary T., Schlauder G., Dawson G., et al. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies. J Med Virol 2008, 80:411-418.
10. El Awady M.K., El-Demellawy M.A., Khalil S.B., Galal D., Goueli S.A. Synthetic peptide-based immunoassay as a supplemental test for HCV infection. Clin Chim Acta 2002, 325:39-46.
11. Ishida C., Matsumoto K., Fukada K., Matsushita K., Shiraki H., Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens. J Clin Microbiol 1993, 31:936-940.
12. Khudyakov Yu E., Khudyakova N.S., Jue D.L., Lambert S.B., Fang S., Fields H.A. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides. Virology 1995, 206:666-672.
13. Chang J.C., Seidel C., Ofenloch B., Jue D.L., Fields H.A., Khudyakov Y.E. Antigenic heterogeneity of the hepatitis C virus NS4 protein as modeled with synthetic peptides. Virology 1999, 257:177-190.
14. Longombardo G., Ferri C., Marchi S., Costa F., Lombardini F., Vacri L., et al. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders. Clin Immunol Immunopathol 1998, 87:124-129.